All PlansCoverageMedium impact
Recall: Albuterol Sulfate
UPMC Health Plan·Pulmonology, Allergy & Immunology, Pediatrics +3 more·Pharmacy
Effective date
Jul 25, 2023
We identified it
Aug 7, 2026
Summary
Cipla US is recalling six batches of Albuterol Sulfate Inhalation Aerosol (90 mcg, 200 metered inhalations) manufactured in November 2021 due to valve leakage that could prevent proper drug delivery. The billing team must identify patients who received this recalled medication and coordinate with providers and pharmacy to ensure affected patients are notified and provided replacement inhalers.
Action Required
Immediately: Billing and clinical teams must coordinate to identify all patients who may have received recalled Albuterol Sulfate batches from November 2021. Contact pharmacy to obtain the specific lot numbers and NDC codes involved in the recall. Clinical staff should notify affected patients and provide replacement inhalers. Billing team should flag any claims related to this recalled medication for potential adjustments or rebilling if replacement therapy is required. Document all communications and replacements in the patient record. Check with payers regarding any billing implications for replacement medications provided due to the recall.